Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"

Authors
Publication date
1 January 2018
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens

    redirect
    oaioai:lib.uoa.gr:uoadl:3107671
    Last time updated on 10/02/2023